– IRELAND, Dublin – UDG Healthcare Plc (LON: UDG), a leading international healthcare services provider, today announced the appointment of Ms Liz Shanahan to its Board of Directors as a Non-Executive Director with effect from 1 February 2020.
The Company also announces changes to the composition of one of its Board Committees, as outlined below.
“We are delighted to welcome Liz, who brings extensive healthcare communications experience to the Board. This combined with her entrepreneurial, M&A and professional services expertise and her insights into healthcare technology developments will inform the continued development of the Group.” said Peter Gray, Chairman of UDG Healthcare.
About Liz Shanahan
Liz is a life sciences entrepreneur with extensive experience advising leading global pharmaceutical and healthcare organisations on their communications. Until 2014, she was Global Head of Healthcare & Lifesciences at the NYSE-listed management consultancy, FTI Consulting Inc., who had in 2007 acquired the communications business, Santé Communications, which she had founded in 1995. She is currently a Trustee of CW+, the charitable arm of Chelsea & Westminster Foundation Trust Hospital in London. She is also a member of the organisation’s Innovations Advisory Board.
Liz has a degree in Computer Programming & Maths from University College Cork, and she is an alumnus of the University of Virginia, Darden School of Business.
About UDG Healthcare Plc
UDG Healthcare Plc is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing 8,700 people with operations in 26 countries and delivering services in over 50 countries.
UDG Healthcare plc operates across two divisions: Ashfield and Sharp.
Ashfield – Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry, operating across three broad areas of activity: advisory, communications and commercial & clinical services. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.
Sharp – Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries, operating from state-of-the-art facilities in the US and Europe.
The company is listed on the London Stock Exchange and is a constituent of the FTSE 250.
For more information: https://www.udghealthcare.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
